Black Rock Inc. Aziyo Biologics, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Aziyo Biologics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 27,566 shares of AZYO stock, worth $39,970. This represents 0.0% of its overall portfolio holdings.

Number of Shares

27,566

Previous 15,238 80.9%

Holding current value

$39,970

Previous $22,000 77.27%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	N/A	12,328 Added 80.9%	27,566 $39,000
Q1 2024 May 10, 2024	BUY	N/A	1,975 Added 14.89%	15,238 $22,000
Q4 2023 Feb 13, 2024	SELL	$1.14 - $1.45 $1,130 - $1,438	-992 Reduced 6.96%	13,263 $19,000
Q3 2023 Nov 13, 2023	SELL	$1.13 - $2.52 $632 - $1,411	-560 Reduced 3.78%	14,255 $20,000
Q2 2023 Aug 11, 2023	BUY	$1.41 - $2.79 $6,576 - $13,012	4,664 Added 45.95%	14,815 $34,000
Q1 2023 May 12, 2023	BUY	$1.19 - $4.96 $392 - $1,636	330 Added 3.36%	10,151 $15,000
Q4 2022 Feb 13, 2023	BUY	$3.48 - $8.94 $1,468 - $3,772	422 Added 4.49%	9,821 $41,000
Q3 2022 Nov 14, 2022	SELL	$5.72 - $7.76 $9,518 - $12,912	-1,664 Reduced 15.04%	9,399 $67,000
Q2 2022 Aug 12, 2022	BUY	$5.75 - $7.41 $26,910 - $34,678	4,680 Added 73.32%	11,063 $78,000
Q1 2022 May 12, 2022	SELL	$4.31 - $7.58 $1,357 - $2,387	-315 Reduced 4.7%	6,383 $38,000
Q4 2021 Feb 10, 2022	BUY	$4.1 - $6.82 $717 - $1,193	175 Added 2.68%	6,698 $42,000
Q3 2021 Nov 09, 2021	SELL	$6.75 - $9.52 $59,109 - $83,366	-8,757 Reduced 57.31%	6,523 $45,000
Q2 2021 Aug 11, 2021	BUY	$9.51 - $13.97 $145,312 - $213,461	15,280 New	15,280 $147,000

Others Institutions Holding AZYO

# of Institutions

Shares Held

12.2M

Call Options Held

Put Options Held

View Full List

About AZIYO BIOLOGICS, INC.

Ticker AZYO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 9,308,720
Market Cap $13.5M
Description
Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of inf...

More about AZYO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account